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Setting a Health Policy Research Agenda for
Controlling Cancer Burden in Korea 
Purpose
The aim of study was to provide suggestions for prioritizing research in effort to reduce 
cancer burden in Korea based on a comprehensive analysis of cancer burden and Delphi
consensus among cancer experts.  
Materials and Methods
Twenty research plans covering 10 topics were selected based on an assessment of the
literature, and e-mail surveys were analyzed using a two-round modified Delphi method.
Thirty-four out of 79 experts were selected from four organizations to participate in round
one, and 21 experts among them had completed round two. Each item had two questions;
one regarding the agreement of the topic as a priority item to reduce cancer burden, and
the other about the importance of the item on a nine-point scale. A consensus was defined
to be an average lower coefficient of variation with less than 30% in importance.
Results
Seven plans that satisfied the three criteria were selected as priority research plans for re-
ducing cancer burden. These plans are “research into advanced clinical guidelines for thy-
roid cancer given the current issue with over-diagnosis,” “research into smoking
management plans through price and non-price cigarette policy initiatives,” “research into
ways to measure the quality of cancer care,” “research on policy development to expand
hospice care,” “research into the spread and management of Helicobacter pylori,” “research
on palliative care in a clinical setting,” and “research into alternative mammography meth-
ods to increase the accuracy of breast cancer screenings.”  
Conclusion
The seven plans identified in this study should be prioritized to reduce the burden of cancer
in Korea. We suggest that policy makers and administrators study and invest significant
effort in these plans.
Key words
Cancer burden, Delphi technique, Agenda, Research plan,
Priority, Thyroid neoplasms, Hospices,
Helicobacter pylori, Early detection of cancer
Introduction
Cancer is a major cause of mortality worldwide, contribut-
ing to 7.6 million deaths and resulting in an estimated 169.3
million years of healthy life lost in 2008 [1]. In Korea, cancer
has been the leading cause of death since 1983, and is associ-
ated with the largest disease burden [2]. 
Deaths from cancer in Korea in 2010 accounted for 28.2%
of all deaths (age-standardized deaths per 100,000 persons:
96.3) and the burden of cancer was ranked first in males
(1,956 per 100,000) and second in females (1,405 per 100,000)
by disability-adjusted life years (DALYs) [2,3]. The economic
burden due to cancer is vast—estimated as 14.1 trillion 
Korean won (KRW, about 13 billion US dollar [USD]) in
South Korea for the year 2005, and  morbidity costs 
accounted for 3.2 trillion won (about 3 billion USD) [4].
Although health spending in Korea is low, at 7.1% of the
gross domestic product (GDP) and lower than the average
of countries belonging to the Organization for Economic
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Cooperation and Development (OECD, 9.7% in 2010; OECD
health data 2013), health care expenditure is expected to rise
sharply due to the retirement of baby-boomers, and cancer
burden is also expected to increase (247,732 new cancer cases
and 74,179 cancer deaths are expected for 2013) [5].
To maximize efficient disease management, research
priorities should be determined in accordance to the disease
burden [6]. Efficient resource allocation and planning of the
use of limited human and financial resources require priori-
tization of research by the government [6]. 
In Korea, the government has implemented several cancer
control projects, including the ‘Action Plan for the 10-Year
Cancer Plan’ from 1996 to 2005, ‘Action Plan for the 2nd
Phase of the 10-Year Cancer Plan’ from 2006, and ‘Cancer
Control 2015: Second Term Comprehensive 10-Year Plan’ in
2011. ‘Action Plan for the 10-Year Cancer Plan’ was success-
ful at building organizations and systems for cancer control,
at providing statistics of national cancer cases, and building
a cancer screening system. In the 2nd phase action plan that
began in 2006, the government invested in the management
of cancer attribute risk factors, early cancer screening for the
whole nation, and expansion of cancer care coverage. In 2009,
based on the interim evaluation report of the ‘Action Plan for
the 2nd Phase of 10-Year Cancer Plan,’ a modified plan was
developed—the ‘Cancer Control 2015: Second Term
Comprehensive 10-Year Plan’—because the cancer burden
and national cancer control situation had changed so rapidly.
Investment and studies based on evidence are needed in
order to reduce cancer burden efficiently. For this, object
selection and priority setting based on objective data and a
comprehensive understanding of the current cancer burden
are required.
In this study, we selected research plans to reduce cancer
burden and conducted a Delphi survey to prioritize cancer
burden-reducing research plans. We suggest research prior-
ities for reducing cancer burden in Korea based on a
comprehensive analysis of the current cancer burden
grounded on a consensus among cancer experts using the
Delphi method. 
Materials and Methods
The Delphi approach refers to the structured, iterative
process of collecting and summarizing opinions from experts
with the goal of forecasting the future events and group
consensus building on a specific issue based on expert opin-
ion [7]. We used a two-round modified Delphi method. We
surveyed a panel of experts, who provided both qualitative
and quantitative feedback for the two rounds [7]. Delphi
method has the advantage of anonymity; thus, decreasing
the chance that some participants may have modified their
responses based on the opinions of highly influential experts
[7].
At first, 10 topics represented by 20 plans were selected.
Topic selection was performed using a two-dimensional
approach: cancer type and attribution factor of burden. An
expert survey was conducted. A consensus was defined as
an average lower coefficient of variation (CV) with less than
30% in importance. Less than the range of CV 0.5 is generally
accepted as stable and was applied conservatively.
Topic subjects were selected by ranking DALYs. According
to the study of Park et al. [8], the five cancer types that are
associated with the greatest cancer burden in Korea are stom-
ach cancer, liver cancer, lung cancer, colon cancer, and breast
cancer (DALYs, 292, 254, 239, 214 and 111 per 100,000, 
respectively). These five types, along with other cancer types
were predicted to have a burden of over 100 DALYs by 2020,
namely thyroid cancer, prostate cancer, and pancreatic
cancer (165, 185, 112 per 100,000 in 2020, respectively), were
selected as topic subjects (DALYs of prostate cancer in 2020
can be confirmed to the author) [8].
Smoking and infection, which have the highest population
attributable fractions (PAFs) to cancer death, were also
included as topic subjects. The PAF of infection is 23.6% and
the PAF of smoking is 22.8% for cancer mortality. Another
risk factor is occupation, but its PAF is relatively low in
comparison (PAF is 8.5) [9]. The PAF of smoking is 73% of
lung cancer deaths, 32% of stomach cancer deaths, and 15%
of liver cancer deaths in Korean males [10]. Furthermore,
approximately 21.2% of all cancers and 24.7% of all cancer
deaths are attributed to infection [11].
A low screening rate is a concern in colon cancer (44.7%),
while the low accuracy of breast cancer screening tests is of
concern [12]. Relevance is well known between the increased
risk of gastric cancer and Helicobacter pylori infection [13]. So,
H. pylori infection control is necessary. Hepatitis B and
hepatitis C are commonly accepted as predisposing factors
that lead to liver cancer. Hepatitis B and hepatitis C infection
studies are needed to reduce the burden of liver cancer.
Thyroid cancer was selected because of its high incidence,
which may reflect over-diagnosis, and cancer types that are
expected to increase in incidence in the future, namely
prostate cancer and pancreatic cancer, were selected to gain
an understanding of current conditions [8]. We also included
topics considered to be important for cancer burden manage-
ment, namely monitoring of the quality of cancer care and
development of hospice-palliative care. 
All 20 plans were selected for consideration of reducing
the burden of cancer by the expert advisory meeting.
Items included in the 10 topics are listed in Table 1, and
we requested “other suggestions” to obtain the opinions of
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individual experts. Each item was associated with two ques-
tions; one regarding the agreement on the selection of the
item as a priority item for reducing cancer burden, and
another about its importance on a 9-point scale. The first
question was “Do you agree with the selection of this
research plan as a priority for reducing cancer burden?,”
while the second question was “How important do you think
this research plan is for reducing cancer burden? Please rank
on a scale from nine (most important) to one (least impor-
tant).” The survey was conducted via e-mail.
All contact between the researchers and participants was
done by e-mail; we did not organize face-to-face or telephone
meetings with experts, either before or after the study. All
correspondence was sent individually to maintain privacy.
Potential participants received an email introducing the
purpose of the study and the nature of their participation,
including the goal of building consensus and explanation of
how topics were selected. Each potential participant received
an online link to the first round survey, and one additional
email was sent to encourage participation. Information about
the results of the prior round was provided to participants
in the second round.
Emails were sent to 79 experts, of which 34 (43%)
completed the first survey. Experts were selected from four
different organizations: National Cancer Center (n=20),
Regional Cancer Center (n=23), Korean Foundation for
Cancer Research (n=7), and Korean Society for Preventive
Medicine (n=29).
A second survey was sent to 34 experts with their answer
and answer-statistics of the first survey (percentage of agree-
ment answers, mean and quartiles of importance answers).
Twenty-one experts responded to the second survey (21/34,
62%) and the affiliated organization of participants are
shown in Table 2. The average CV of the importance criterion
of the second survey was 29.4%; therefore, no more survey
cycles were conducted.
The priority items were decided based on predetermined
thresholds for the three criteria of agreement, importance,
and conformity (Table 3). Items satisfying the thresholds for
these criteria were selected as priority research plans for
reducing cancer burden. Ranking was determined in accor-
dance to importance. The items that satisfied two criteria
were selected as secondary priority research plans.
Results
Results from the second Delphi survey are shown in Table
4, and priority research plans and other suggestions for
reducing cancer burden in Korea are shown in Table 5. Other
suggestions were classified into four categories.
Seven plans were selected as priority plans for reducing
cancer burden—“Advanced clinical guidelines for thyroid
cancer given the current issue of over-diagnosis need to be
Table 2. Affiliations of Delphi surveyees
Respondent
Classification Organization No. of subjects
First survey Second survey 
Cancer center National Cancer Center 20 13 9
Regional Cancer Center 23 6 3
Researcher Korean Foundation for Cancer Research 7 2 1
The Korean Society for Preventive Medicine 29 13 8
Total 79 34 21
Table 3. Criteria for selecting priority plans
Criterion Substance
Agreement Agreement percent  90% 
Importance Average importance scale  6.5 
Conformity Agreement percent difference between cancer center group and researcher group < 10%
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developed,” “Research into smoking management plans,
particularly price and non-price cigarette policy initiatives,
should be conducted,” “Research into ways to measure the
quality of cancer care should be conducted,” “Policies to
expand hospice care should be developed,” “Studies on the
spread and management of H. pylori should be conducted,”
“Research on application of palliative care in a clinical cancer
setting should be conducted," and “Alternative mammogra-
phy methods to increase the accuracy of breast cancer screen-
ings should be researched” (sub-titles 5-1, 8-1 9-1, 10-2, 2-3,
10-1, and 4-2, in order of importance). “Mammography
management plans that increase the accuracy of breast cancer
screening should be investigated,” “Substitution of fecal
occult blood test (FOBT) for colonoscopy should be investi-
gated to increase the low colorectal cancer screening rate,"
and “Clinical guidelines for former cancer patients should
be drawn up” (sub-titles 4-1, 1-1, and 10-3) were selected as
secondary priority plans. “Advanced clinical guidelines for
thyroid cancer given the current issue of over-diagnosis need
to be developed,” “Research into smoking management
plans, particularly price and non-price cigarette policy
initiatives, should be conducted,” and “Research into ways
to measure the quality of cancer care should be conducted”
(sub-titles 5-1, 8-1, and 9-1) were ranked first, second, and
third, respectively, based on the results from both rounds of
the survey. “Policies to expand hospice care should be
developed” and “Research on application of palliative care
in a clinical cancer setting should be conducted” (sub-titles
10-2 and 10-1) were also selected in both the first and second
surveys. “Studies on the spread and management of H. pylori
should be conducted” and “Alternative mammography
methods to increase the accuracy of breast cancer screenings
should be researched” (sub-titles 2-3 and 4-2) were not
selected in the first survey, but were newly selected during
the second survey.
The average CV of importance was 32.1% for the first
survey and 29.4% for the second survey.
Discussion
We used the Delphi method to select priority research
plans to reduce future cancer burden in Korea. The incidence
of thyroid cancer has increased in recent decades in Korean
woman (10.6/100,000 in 1996 to 111.3/100,000 in 2010), but
mortality was only 0.4 in 2010 [14]. This is similar to what
has been observed in the United States, Scotland, and Aus-
tralia [15]. Davies and Welch [15] suggested that the increas-
ing incidence reflects increased detection of subclinical
disease. It is thought that advanced clinical guidelines are
therefore needed.
Some early studies suggested that tax increase led to
declines in smoking rates [16]. One of the most noteworthy
measures implemented was a cigarette tax increase in
December 2004, leading to an increase in the average retail
price of cigarettes by 29%, in South Korea [16]. This large tax
increase represented an explicit policy goal to reduce 
smoking rates, which was the first time in Korean history
[16,17]. Since 2004, no other political measures have been
attempted. Cigarette sales are decreasing in Korea, but at a
slow rate. There have been many disputes over how to
modify smoking in Korea by altering the price of cigarettes.
However, few studies have examined how smoking can be
controlled by pricing measures. Research into plans to
manage smoking by price control is therefore very impor-
tant.
According to Korean meta-analysis, there are just a few
studies that studied cancer pain and psychosocial interven-
tion. Furthermore, there are minimal number of studies
concerning other qualities of cancer patients [18]. Studies on
the quality of cancer patients are a necessity in South Korea,
since the number of cancer patients have reached up to
960,654, and 202,053 patients were newly diagnosed cancer
in 2010 [2].
Hospice care and palliative care are also of great impor-
tance—there are an estimated 1 million cancer survivors in
South Korea, and 1.9% of the population has received cancer
treatment or survived after cancer treatment [19]. Neverthe-
less, there were only 722 beds for palliative care of cancer
patients in 2011. Development of plans for hospice and
palliative care will have a major impact on reducing cancer
burden.
The International Agency for Research on Cancer and the
World Health Organization (IARC/WHO) concluded in 1994
that there was a positive causal linkage between H. pylori and
gastric carcinogenesis, and numerous epidemiological stud-
ies have shown an association between H. pylori infection and
increased risk of gastric cancer. Although the prevalence of
H. pylori has decreased from 64.7% in 1998 to 40.0% in 2005,
it still remains high, especially in younger individuals (44.1%
in 19-39-year-olds, 42.6% in 40-59-year-olds, and 28.3% in
individuals over 60 years) [20]. Therefore, further studies are
required to investigate the spread of H. pylori and develop
management plans.
However, some recent studies have questioned the associ-
ation between H. pylori infection and gastric cancer. Yoon et
al. demonstrated that 5.4% cases of gastric cancer in South
Korea are H. pylori negative [21]. Khanna [22] reported a
higher prevalence of H. pylori (80%) in the control group than
the gastric cancer case group (78%). Further studies are 
therefore required to determine if there is in fact a causal 
relationship between the occurrence of gastric cancer and H.
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pylori (sub-sections 2-1 and 2-2), even though this was not 
selected as a priority research plan.
Lastly, worldwide randomized controlled trial study
conducted on the basis of screening by mammography in
breast cancer mortality showed only about 20% mortality
reduction [23]. Another study reports that the screening
effect of mammography, excluding time effect, is about 10%
[24]. For this reason, the US Food and Drug Administration
(FDA) suggested delaying the age of breast cancer screening
and lowering the number of screening. It is necessary to 
increase the accuracy of mammography to overcome these
results. Due to concerns about the accuracy of breast cancer
screening with mammography, researchers have been using
an ultrasound or magnetic resonance imaging for screening
in addition to mammography [25]. A cost-effectiveness eval-
uation of alternative methods is also needed. 
This study has some limitations. First, we proposed survey
items rather than letting the surveyees propose research
topics. However, the subject fields of cancer and cancer
burden are very large, and we wanted to present surveyees
with a comprehensive range of topics. Therefore, we sug-
gested 20 plans according to expert advisory with 10 topics.
We determined the agreement among researchers for each
item in the survey and selected items that had high agree-
ment ( 90%). For this item, to reduce plan selection problem,
we have set the standard that is 10% less than the difference
between the agreement of clinical experts and researchers.
We also included “other suggestions” section in the survey.
In future studies, these “other suggestions” should be
considered.
Second, the makeup of surveyees was biased towards
non-clinical researchers. However, experts in cancer centers
are field workers; so, we divided the experts into two groups:
a cancer center group and a researcher group, and evaluated
the differences between these two groups (our criterion of
conformity). 
Third, the cut-off value of agreement, one of the criteria is
not objective. However, we made a proposal based on the
order of agreement. Thus, a cut-off value might not have an
effect on the priority ordering of plans.
Last, this study does not suggest any detail models or
political direction of plans, and just suggests priority health
policy research plans for reducing future cancer. We believe
that a study regarding these research plans for suggesting
national political direction and success model is needed.
However, despite our limitations, we believe that our find-
ings are important and should be used to prioritize funding
for research projects with the ultimate goal of reducing
cancer burden.
Conclusion
We propose seven prioritized research plans that should
be implemented to reduce cancer burden in South Korea. 
In particular, the study about over-diagnosis of thyroid
cancer will be a useful research worldwide, and price policy
of cigarette will have much effectiveness in the domestic
realm. Furthermore, in the context of the rapid aging of the
population, we do not have enough time to prepare to study
for the "quality of cancer treatment," "hospice care," and
"palliative care". In addition, research for screening and treat-
ment, which is currently being conducted, should not be
neglected.
We urge policy makers and administrators to invest in
these plans.  
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